Pharmacokinetic interactions between the hormonal emergency contraception, levonorgestrel (Plan B), and efavirenz

Infectious Diseases in Obstetrics and Gynecology

Volumn 2012, Issue , 2012, Pages

  Carten, Monica L ^a   Kiser, Jennifer J ^a   Kwara, Awewura ^b   Mawhinney, Samantha ^a   Cu Uvin, Susan ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; LEVONORGESTREL; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BENZOXAZINE DERIVATIVE; CONTRACEPTIVE AGENT;

ABDOMINAL PAIN; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXPOSURE; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EMERGENCY CONTRACEPTION; FATIGUE; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; INSOMNIA; LIVER FUNCTION TEST; MAXIMUM PLASMA CONCENTRATION; MENSTRUAL CYCLE; NORMAL HUMAN; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; SIDE EFFECT; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT WITHDRAWAL; DRUG COMBINATION; DRUG INTERACTION; MIDDLE AGED; PHARMACOKINETICS;

ADULT; ANTI-HIV AGENTS; AREA UNDER CURVE; BENZOXAZINES; CONTRACEPTIVE AGENTS, FEMALE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEVONORGESTREL; MIDDLE AGED; PROSPECTIVE STUDIES; THERAPEUTIC EQUIVALENCY; YOUNG ADULT;

EID: 84858121160     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1155/2012/137192     Document Type: Article

References (22)

1. HIV/AIDS Surveillance Report, Cases of HIV and AIDS in the United States and Dependent Areas 2007
2. UNAIDS,. AIDS Epidemic Update: December 2005
3. Sustiva (Efavirenz) Capsule and Tablets.US Prescribing Information 2010 Princeton, NJ, USA Bristol-Myers-Squibb
4. Saitoh A., Hull A. D., Franklin P., Spector S. A., Myelomeningocele in an infant with intrauterine exposure to efavirenz Journal of Perinatology 2005 25 8 555 556 (Pubitemid 41122407)
5. Fundar C., Genovese O., Rendeli C., Tamburrini E., Salvaggio E., Myelomeningocele in a child with intrauterine exposure to efavirenz AIDS 2002 16 2 299 300 (Pubitemid 34118582)
6. De Santis M., Carducci B., De Santis L., Cavaliere A. F., Straface G., Periconceptional exposure to efavirenz and neural tube defects Archives of Internal Medicine 2002 162 3 355 (Pubitemid 34127415)
7. Massad L. S., Springer G., Jacobson L., Watts H., Anastos K., Korn A., Cejtin H., Stek A., Young M., Schmidt J., Minkoff H., Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV AIDS 2004 18 2 281 286 (Pubitemid 38253451)
8. Van Benthem B. H., De Vincenzi I., Delmas M. C., Pregnancy bfore and after HIV diagnosis in a European cohort of HIV-infected women. European study on the natural history of HIV infection in women AIDS 2000 14 14 2171 2178
9. Finner L. B., Henshw S. K., Disparities in rates of unintended pregnancy in the United States, 19942001 Perspect Sex Reprod Health 2006 38 2 9 96
10. Plan B (LNG0.75) Tablets, US Prescribing Information 2006 Pomona, NY, US Barr Pharmaceuticals Inc.
11. Task Force on Postovulatory Methods of Fertility Regulation, Randomized controlled trial of levonorgestrel versus the yuzpe regimen of combined oral contraceptives for emergency contraception The Lancet 1998 352 9126 428 433
12. Cohn S. E., Park J. G., Watts D. H., Stek A., Hitti J., Clax P. A., Yu S., Lertora J. J. L., Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions Clinical Pharmacology and Therapeutics 2007 81 2 222 227 (Pubitemid 46174819)
13. Sevinsky H., Eley T., He A., Persson D., Effect of efavirenz on the pharmacokinetics of ethinyl estradiol and norgestimate in healthy female subjects Proceedings of the 48th Annual ICAAC/IDSA 46th Annual Meeting October 2008 Washington, DC, USA
14. Matiluko A., Soundararjan L., Hodston P., Early contraceptive failure of implanon in an HIV-seropositive patient on triple antiretroviral therapy with zidovudine, lamivudine and efavirenz Journal of Family Planning and Reproductive Health Care 2007 33 4 277 278 (Pubitemid 47597636)
15. Kook K., Gabelnick H., Duncan G., Pharmacokinetics of levonorgestrel 0.75mg tablets Contraception 2002 66 1 73 76
16. Gandhi M., Benet L., Bacchetti P., Kalinowski A., Anastos K., Wolfe A. R., Young M., Cohen M., Minkoff H., Gange S. J., Greenblatt R. M., Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women Journal of Acquired Immune Deficiency Syndromes 2009 50 5 482 491
17. El-Ibiary S., Cocohoba J., Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives European Journal of Contraception and Reproductive Health Care 2008 13 2 123 132 (Pubitemid 352000659)
18. Vogler M., Patterson K., Kamemoto L., Park J. G., Watts H., Aweeka F., Klingman K. L., Cohn S. E., Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188 Journal of Acquired Immune Deficiency Syndromes 2010 55 4 473 482
19. Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents, US Department of Health and Human Services. 2010, http://www.aidsinfo.nih.gov/guidelines/adult/AA 100606.pdf
20. Crawford P., Chadwick D. J., Martin C., Tjia J., Back D. J., Orme M., The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids British Journal of Clinical Pharmacology 1990 30 6 892 896
21. Sidhu J., Job S., Singh S., Philipson R., The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects British Journal of Clinical Pharmacology 2006 61 2 191 199 (Pubitemid 43382612)
22. Barditch-Crovo P., Trapnell C. B., Ette E., Zacur H. A., Coresh J., Rocco L. E., Hendrix C. W., Flexner C., The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive Clinical Pharmacology and Therapeutics 1999 65 4 428 438 (Pubitemid 29196547)